Whatman Share Discussion Threads

[rmjpb] 02/2/2005 08:04

Sorry but I could not find it.

[polyman] 01/2/2005 13:58

A new web site www.whatmanshareholders.org has been set up.

[mashman] 29/1/2005 14:32

"BioSource Releases First Protein Microarray to Quantify Specific Phosphorylation of Proteins

BioSource International, Inc. (Nasdaq:BIOI), today announced that it has commercialized the first multiplex protein microarray able to quantifiably and reproducibly measure multiple phosphorylated proteins in one sample, the Mercator(TM) PhosphoArray. Through collaboration with Whatman(R) Schleicher & Schuell(R), BioSource has produced a novel assay capable of altering the methods whereby scientists can study protein phosphorylation for the research of disease.


Whatman Schleicher & Schuell is a leader in protein array technology beginning with the development of the FAST Slide, the premier protein arraying surface. The nitrocellulose surface, combined with BioSource's extensive experience in Signal Transduction assay development, has led to a highly sensitive, rapid and reproducible assay that simultaneously quantifies 10 phosphoproteins. BioSource will offer a scanning service allowing any researcher to use the array without the barrier of instrumentation.

"Mercator(TM) PhosphoArrays provide a wealth of information about a signaling system from one of the most innovative technologies on the market," said Terrance Bieker, BioSource's President and Chief Executive Officer. "The information resulting from the application of this technology should provide scientists with important data on cell systems across multiple pathways, giving insight into disease states," Mr. Bieker continued.

Dr. Robert Negm, Director, Business Development of Whatman Schleicher & Schuell stated, "We are very pleased with this product resulting from our partnership with BioSource, as it will substantially increase the number of cell-signaling scientists who may benefit from combining our focus in protein microarray technology with BioSource's strengths in developing market-leading immunoassay reagents."

This multiplex protein microarray product is the first of what is intended to be a broad line of BioSource protein microarrays capable of targeting disease research in oncology, neurobiology and inflammation. The product enhances BioSource's position as a market leader in providing quantitative Signal Transduction phosphoELISAs(TM).

About BioSource International, Inc.

BioSource International, Inc. is a broad-based life sciences company focused on providing integrated solutions in the areas of functional genomics, proteomics, and drug discovery through the development, manufacturing, marketing, and distribution of unique, biologically active reagent systems which facilitate, enable, and accelerate pharmaceutical development and biomedical research. For more information, please visit the Company's Web site at www.biosource.com. "

[mashman] 15/1/2005 09:28

Whatman takes interim step
By Ruth Sullivan
Published: January 14 2005 02:00 | Last updated: January 14 2005 02:00

Management changes continue at Whatman where Thomas McNally,a non-executive, moves to the newly-created role of vice-chairman.


As the supplier of separations technology to the life sciences industry, Mr McNally will take executive responsibility for R&D, business development and sales, tasks previously carried out by Howard Kelly, former chief executive who left in November. Mr Kelly is the second chief executive to be ousted since Bob Thian became chairman in 2002.

Based at the company's US headquarters in New Jersey, Mr McNally will continue in the new role until the appointment of a new chief executive.

The company said Mr Thian would take responsibility for the integration and management of Schleicher & Schuell, the German separations company acquired by Whatman two months ago.

At the same time, Hinrich Kehler, who was until recently chairman of Schleicher & Schuell, becomes a non-executive director. Ruth Sullivan




Whatman: Board Changes
01/14/2005 - Whatman PLC announced the appointment of Mr Thomas McNally, an existing non-executive Director of Whatman, as Vice Chairman of the Company, and the appointment of Dr. Hinrich Kehler as a non executive Director.

In his new role, Mr McNally will take executive responsibility for the R&D, Business Development and Sales functions previously carried out by Howard Kelly, the former Chief Executive who stood down from his post in November. Based at Whatman's US headquarters in Florham Park, New Jersey, he will continue in this role until the appointment of a new Chief Executive, the search for which is now underway. Bob Thian, Chairman of Whatman, will take responsibility for the integration and management of Schleicher & Schuell GmbH, the German separations company acquired by Whatman at the end of November.

Mr McNally enjoyed a highly successful 25 year career with Abbott Laboratories Inc. including increasingly senior assignments in the Diagnostics, International and Ross Laboratories Divisions. Prior to joining Abbott, he was commissioned as a naval officer and spent time with Mobil Oil and Xerox.

Dr. Hinrich Kehler was until recently the Chairman of Schleicher & Schuell and has extensive experience at board level. For the last four years he has been CEO of ConCap GmbH, a consulting and venture capital firm focusing on technology processing companies. Prior to that in 1996 he became Chairman and CEO of the Sebaldus Group, an integrated media company, where he significantly enhanced the Company's value. He holds a PhD in physical chemistry with a particular focus on separations chemistry.

[mashman] 13/1/2005 20:06

049balt, all i see is Nomura downgrade from hold to neutral. Is that the same as you? There does seem to have been some offloading at this level and a brokers downgrade could mean its over.

[049balt] 13/1/2005 18:22

Broker downgrade,

[rmjpb] 13/1/2005 13:38

Bit of a recorrection today. No new news though, so a bit surprised at the over reaction. I guess all the heavies were on holiday on the 31st Dec so did not read the company statement. The new directors look impressive enough.

[mashman] 12/1/2005 13:05

Thanks sweeneytodd.

[sweeneytodd] 12/1/2005 12:58

Thought you guys might be interested to know that Jupiter Enviromental Opportunities Fund holds Whatman as its third biggest holding,its 1st in Citywires top 3month Funds.

[go with the flow] 12/1/2005 12:06

Great research Mashman!
Very promising strategy, glad I held.

Flow

[brugha] 12/1/2005 11:31

Very, very tasty

[mashman] 12/1/2005 07:36

Whatman Schleicher & Schuell Enters Kinase Target Drug Screening Markets Through PepChip(R) Kinase License From Pepscan Systems

[brugha] 10/1/2005 19:26

I'm very impressed that we have continued to rise despite the grim update

A lot more to come I suspect :)

[go with the flow] 07/1/2005 14:39

Quite impressed with the recovery despite the increased restructuring costs, the City must believe WHM are worth underpinning.
At least we now know the reason for the CEO sacking so it should all be out in the open now. So let's have some better news or at least better timed news!

Flow

[mashman] 06/1/2005 15:27

Well it doesn't look like we are going down to the woods to play with the bears and if we get another rise tomorrow we will be back on the 50 day ma.
Here's to a nice steady rise through 2005.

[mashman] 01/1/2005 10:38

I dont know what the spike to £3 is all about on the chart above so here is an ADVFN chart. Does anyone know if ADVFNs rsi is correct because it doesn't look right.

[herbyone] 31/12/2004 18:49

The trading statement in July prior to the interim results on 28 September said operating profit and sales grpwth ahead of expectations prior to goodwill and exceptional items. Some exceptional item that they must have known was in the pipeline!! I agree Tuesday will be the crunch day, hopefully the price will hold above 220

[kenmill] 31/12/2004 12:24

It looks as though they are using the circumstances of the acquisition to clear the decks for clean figures going forward. The price has stabilised and there is small buying taking place. Tuesday will be the crunch day with everybody updated on the position.

[ramblerman] 31/12/2004 11:21

It's keywords like "disappointing" that some investors notice and then push the sell button microseconds later. See following from today's announcement:

"Whatman's (excluding S&S) full year sales are disappointing at around 3% below
expectations, but earnings before exceptional charges remain in line with
consensus for the year".

I will hold as I expect the price to recover

[brugha] 31/12/2004 08:51

I'd say what they have announced is worse than what BPRG announced.

Could easily get hammered a lot further down

[rmjpb] 31/12/2004 08:48

Did not like the drop in sales.

[green sand] 31/12/2004 08:45

The reaction, imo, is well over done to a planned reorg, it is a buying op.

GS